Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Embleema is a healthcare technology company that provides a regulatory-grade health data platform designed to accelerate the development of precision medicines. The company's platform, which includes the HIVE bioinformatics system used by the FDA, unifies clinical, molecular, and real-world data to generate evidence for regulatory reviews. Embleema utilizes blockchain technology to manage patient consent and data sovereignty, allowing patients to securely share their medical records with researchers and life sciences companies. By streamlining data collection and analysis, Embleema helps pharmaceutical companies and research institutions conduct more efficient clinical trials and real-world evidence studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Embleema Global Health Consortium.